Literature DB >> 19787747

High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.

Niraj Kumar Srivastava1, Sunil Pradhan, Balraj Mittal, G A Nagana Gowda.   

Abstract

Proton NMR spectroscopic investigations on the lipid extract of the serum of 41 Duchenne muscular dystrophy (DMD) (age, mean +/- SD; 8.0 +/- 3.0 years) patients and 22 healthy subjects (age, mean +/- SD; 9.0 +/- 4.0 years) were performed in the northern Indian population. The concentration of triglycerides, phospholipids, free cholesterol, cholesterol esters and total cholesterol was significantly higher in DMD patients as compared to healthy subjects. Ratio of free-cholesterol to cholesterol-esters was also significantly higher in DMD patients. Among the individual lipids, concentration of phospholipids was found to be consistently higher in DMD patients compared to healthy subjects, with a discriminatory index of 87.5%. The highest discriminatory index of 92% was found along with the ratio of PL (phospholipids) to CHOL (cholesterol), i.e. PL/CHOL. No significant quantitative difference was observed in the serum lipid constituents of positive and negative gene deletion cases of DMD. The inferences drawn from this study may provide the possibility of the diagnostic importance for DMD, especially in cases where genetic analysis fails to provide the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19787747     DOI: 10.1002/nbm.1419

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  17 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

3.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

4.  Age-dependent changes in metabolite profile and lipid saturation in dystrophic mice.

Authors:  Brittany Lee-McMullen; Stephen M Chrzanowski; Ravneet Vohra; Sean C Forbes; Krista Vandenborne; Arthur S Edison; Glenn A Walter
Journal:  NMR Biomed       Date:  2019-03-08       Impact factor: 4.044

5.  Abnormal lipid metabolism in a rat model of arthritis: one possible pathway.

Authors:  Niraj Kumar Srivastava; Shikha Sharma; Neeraj Sinha; Sudhir Kumar Mandal; Deepak Sharma
Journal:  Mol Cell Biochem       Date:  2018-02-21       Impact factor: 3.396

6.  Altered lipid metabolism in post-traumatic epileptic rat model: one proposed pathway.

Authors:  Niraj Kumar Srivastava; Somnath Mukherjee; Rajkumar Sharma; Jharana Das; Rohan Sharma; Vikas Kumar; Neeraj Sinha; Deepak Sharma
Journal:  Mol Biol Rep       Date:  2019-01-31       Impact factor: 2.316

7.  A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.

Authors:  Nicholas P Whitehead; Min Jeong Kim; Kenneth L Bible; Marvin E Adams; Stanley C Froehner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

8.  Circulating Biomarkers for Duchenne Muscular Dystrophy.

Authors:  Annemieke Aartsma-Rus; Pietro Spitali
Journal:  J Neuromuscul Dis       Date:  2015-07-22

9.  Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Nadia Milad; Zoe White; Arash Y Tehrani; Stephanie Sellers; Fabio M V Rossi; Pascal Bernatchez
Journal:  Skelet Muscle       Date:  2017-09-12       Impact factor: 4.912

10.  Plasma lipidomic analysis shows a disease progression signature in mdx mice.

Authors:  Roula Tsonaka; Alexandre Seyer; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.